Cholbam

One, Two, Three . . . and They’re Out! FDA Issues Third Rare Pediatric Disease Priority Review Voucher, Triggering One-Year Sunset Clause
FDA Law Blog
Tue, 03/24/15 - 10:15 am
FDA
pediatrics
Cholbam
Retrophin bags rare disease approval, FDA voucher in $75M deal
Fierce Biotech
Wed, 03/18/15 - 11:30 am
Retrophin
FDA
Cholbam